Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deli... (ated for treatment ofbypass stenosis ane...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability

Date:6/2/2008

ated for treatment of bypass stenosis, aneurysms and for emergency situations such as perforations.

About ITGI Medical

ITGI medical is engaged with research and development, manufacturing and marketing of heterologous tissue covered stents. Over and Under(R) is the first among series of heterologous covered stents designed to treat coronary lesions and aneurysms.

Contact:

Danna Moran

Director of Marketing

ITGI Medical Ltd.

P: + 972-72-2200335

dannam@itgimedical.com

SOURCE ITGI Medical LTD
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth
2. National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications
3. National Stem Cell Holding in Final Stage Negotiations for Exclusive Licensing of its Recently Discovered Biomaterial for Anti-Aging Applications
4. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
5. Preclinical Research on Coronary Stent with CeloNova BioSciences Polyzene(R)- F Nanocoating Receives Award at CIRSE 2007
6. ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients
7. PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
8. Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
9. CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVTs Innovative Stent Coating Technology
10. Tryton Medical Receives CE Mark Approval for its Side-Branch Stent
11. Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents

Post Your Comments:

Breaking Biology Technology:Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 2 Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 3 34th Annual Hutch Holiday Gala Raises More Than $7 Million For Cancer Research 2 34th Annual Hutch Holiday Gala Raises More Than $7 Million For Cancer Research 3 Vivakor Confirms Record Date of Stock Dividend 2 Vivakor Confirms Record Date of Stock Dividend 3 BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2 BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3 BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4

[0] Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. [0] 34th Annual Hutch Holiday Gala Raises More Than $7 Million For Cancer Research [0] Vivakor Confirms Record Date of Stock Dividend [0] BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year

Other Biology Technology:ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting 2 ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting 3 ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting 4 ViroPharma Enhances Leadership to Support Global Growth and Expanding Business 2 ViroPharma Enhances Leadership to Support Global Growth and Expanding Business 3 ViroPharma Enhances Leadership to Support Global Growth and Expanding Business 4 ViroPharma Enhances Leadership to Support Global Growth and Expanding Business 5 Pharmaxis Aridol Approved for Sale in Switzerland 2

ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting ViroPharma Enhances Leadership to Support Global Growth and Expanding Business Pharmaxis Aridol Approved for Sale in Switzerland

Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2 How to read brain activity? 2 New therapy targets for amyloid disease 2 Sex With New Partners Raises Widowers Disease Risk 57941 1 Sex With New Partners Raises Widowers Disease Risk 57941 2 URAC Open Public Comment Period for New Independent Review Organization Standards 57939 1 URAC Open Public Comment Period for New Independent Review Organization Standards 57939 2 URAC Open Public Comment Period for New Independent Review Organization Standards 57939 3 Juice Newton Performs Benefit Concert to Support Dystonia Research 57937 1 Juice Newton Performs Benefit Concert to Support Dystonia Research 57937 2

[0] Lower income women report more insurance-based discrimination during pregnancy, delivery [0] How to read brain activity?[0] New therapy targets for amyloid disease

Other Biology News:VIB and Bayer join forces for plant research 2 VIB and Bayer join forces for plant research 3 Sleep restriction results in increased consumption of energy from snacks 2 A protein sequence associated with Huntington’s disease may become life-saving vaccine component 2

VIB and Bayer join forces for plant research Sleep restriction results in increased consumption of energy from snacks A protein sequence associated with Huntington’s disease may become life-saving vaccine component

Biology Products:

Sealed Ice Blocks, for Criterion blotter, 2 from Bio-Rad DNA Engine Tetrad 2 Thermal Cycler Chassis from Bio-Rad SVT3-2 Diverter Valve from Bio-Rad 4',6-Diamidino-2-phenylindole, dihydrochloride (DAPI) from Pierce Biotechnology, Inc.